Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)

被引：0
|
作者：
Gupta, Santosh
Halabi, Susan
Kemeny, Gabor
Anand, Monika
Nanus, David M.
Giannakakou, Paraskevi
George, Daniel J.
Gregory, Simon
Armstrong, Andrew J.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Duke Univ, Durham, NC USA
[4] Sandra & Edward Meyer Canc Ctr, New York, NY USA
[5] Weill Cornell Med, Meyer Canc Ctr, New York, NY USA
[6] Duke Univ, Sch Med, Durham, NC USA
[7] Duke Canc Inst, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
147
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Screening and baseline analysis of circulating tumor cell (CTC) counts and androgen receptor (AR) localization with clinical characteristics of men with metastatic castration-resistant prostate cancer (mCRPC) in TAXYNERGY
    Tagawa, S. T.
    Galletti, G.
    Antonarakis, E. S.
    Tasaki, S.
    Gjyrezi, A.
    Worroll, D.
    Portella, L.
    Kirby, B. J.
    Stewart, J.
    Zaher, A.
    Saad, F.
    Vanhuyse, M.
    Suri, S.
    Lannin, T. B.
    Gruber, C.
    Pratt, E.
    North, S.
    Eisenberger, M. A.
    Nanus, D. M.
    Giannakakou, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S498 - S499
  • [22] Baseline and post-treatment circulating tumor cell (CTC) counts with prostate-specific membrane antigen (PSMA)-targeted radionuclide therapy (TRT) in men with metastatic castration-resistant prostate cancer (mCRPC).
    Sun, Michael
    Lebenthal, Justin M.
    Nauseef, Jones T.
    Niaz, Muhammad Junaid
    Guervil, Sabrina
    Fernandez, Escarleth
    Patel, Amie
    Tan, Angela
    Vlachostergios, Panagiotis J.
    Osborne, Joseph
    Molina, Ana M.
    Sternberg, Cora N.
    Nanus, David M.
    Bander, Neil Harrison
    Tagawa, Scott T.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [23] Correlation between genomic alterations and germline mutations in men with metastatic castration-resistant prostate cancer (mCRPC)
    Llacer Perez, C.
    Oliva Fernandez, L.
    Canada-Higueras, E.
    Saez, M. I.
    Villatoro, R.
    Montesa Pino, A.
    Herrera Imbroda, B.
    Hernandez, D.
    Lozano Mejorada, R.
    Romero Laorden, N.
    Marquez, M.
    Grau, G.
    Pineda, A.
    Lopez, F. J.
    Peinado, P.
    Alameda, D.
    Olmos, D.
    Castro, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S641 - S642
  • [24] Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer
    Rini, Brian I.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (03) : 163 - 164
  • [25] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Bilusic, Marijo
    Karzai, Fatima
    Cordes, Lisa M.
    Strauss, Julius
    Schlom, Jeffrey
    Gulley, James L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] ARN-509 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Rathkopf, Dana E.
    Antonarakis, Emmanuel S.
    Shore, Neal D.
    Tutrone, Ronald
    Alumkal, Joshi J.
    Ryan, Charles J.
    Saleh, Mansoor N.
    Hauke, Ralph J.
    Maneval, Edna Chow
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [27] Pembrolizumab in men with heavily treated metastatic castration-resistant prostate cancer (mCRPC).
    Tucker, Matthew D.
    Zhu, Jason
    Berry, William R.
    Ramalingam, Sundhar
    Zhang, Tian
    Harrison, Michael Roger
    Wu, Yuan
    Healy, Patrick
    George, Daniel J.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [28] Avelumab in metastatic castration-resistant prostate cancer (mCRPC).
    Fakhrejahani, Farhad
    Madan, Ravi Amrit
    Dahut, William L.
    Karzai, Fatima
    Cordes, Lisa M.
    Schlom, Jeffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [29] Circulating tumor cells in metastatic castration-resistant prostate cancer
    Brian I. Rini
    Current Oncology Reports, 2009, 11 : 163 - 164
  • [30] Genomic analysis of circulating tumor cells (CTCs) from men with metastatic castration resistant prostate cancer (mCRPC) in the context of enzalutamide therapy.
    Li, Jing
    Beaver, Joshua
    Bitting, Rhonda Lynn
    Gregory, Simon
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345